The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 129 participants.

Also called NCT04519489

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 129 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04519489
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04519489. Randomized; no masking; primary purpose treatment. Start 2020-09-18 (actual); primary completion 2021-12-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA
Acronym
AFOSA
Condition
Obstructive Sleep Apnea
Intervention (Device)
PAP therapy with telemonitoring
Intervention (Other)
AF standard management and OSA general care
Lead sponsor
Philips (China) Investment CO., LTD (class: industry)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Beijing Tsinghua Changgeng Hospital (class: other)
Collaborator
Beijing Tongren Hospital (class: other)
Collaborator
Fu Wai Hospital, Beijing, China (class: other)
Collaborator
Shanghai 6th People's Hospital (class: other)
Collaborator
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct04519489
Content hash
9ee16df8ef10129712002d67fe98d73ef101fc582e2c0cd650bb878bd7ebe3a7